Strontium and fractures

What 3 graded rows on strontium agree on for fractures, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Strontium page, with its PubMed record.

Your question

Supplement
Strontium Choose another

Strontium and fractures

3 rows · 11,822 people

They agree: all 3 rows found an improvement.

No difference
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade A× 1
  • Grade B× 2
Rows
3
Trials
4
People
11,822
Pooled reviews may count some twice

What the rows share

From the rows

The best-graded row, grade A, is a meta-analysis of 5,082 people (2006) and found an improvement.

The rows run from 1,649 to 5,091 people, published from 2004 to 2006: 1 pooled review and 2 single studies.

The rows

3 improved
  1. Grade AVertebral and non-vertebral fractures (strontium ranelate, pooled) · Improved

    Meta-analysis, 2 studies · n 5,082 · 2006 · Postmenopausal women with osteoporosis (4 trials; vertebral analysis from 2 trials)

    2 g/day (lower doses 0.125–1 g/day in other arms) · 3 years

    Vertebral fractures fell by 37% (RR 0.63) and non-vertebral fractures by 14% (RR 0.86; n = 6,572). Diarrhoea was more common, and vascular and nervous-system side effects were slightly increased with 2 g/day.

    Row on the Strontium page · PubMed 16856092 (opens PubMed)

  2. Grade BNon-vertebral and hip fractures (strontium ranelate) · Improved

    RCT · n 5,091 · 2005 · Postmenopausal women with osteoporosis (TROPOS trial)

    2 g/day · 3 years (main analysis of a 5-year study)

    All non-vertebral fractures fell by 16% (P = 0.04) and major fragility fractures by 19%; in a high-risk subgroup (age 74+ with very low hip BMD) hip fractures fell by 36% (P = 0.046).

    Row on the Strontium page · PubMed 15728210 (opens PubMed)

  3. Grade BNew vertebral fractures (strontium ranelate) · Improved

    RCT · n 1,649 · 2004 · Postmenopausal women with osteoporosis and at least one vertebral fracture (SOTI trial)

    2 g/day · 3 years

    New vertebral fractures fell by 49% in year 1 and 41% over 3 years (RR 0.59); lumbar spine BMD rose 14.4% and femoral neck 8.3%. Serious adverse events did not differ in the published report.

    Row on the Strontium page · PubMed 14749454 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.